Download DNB 2019 Dec 2019 Dec Cardio Thoracic Surgery PAPER III Question Paper

FirstRanker.com

FINAL EXAM

DECEMBER 2019

--- Content provided by⁠ FirstRanker.com ---

Time: 3 hours

CARDIO THORACIC SURGERY

PAPER-III

Max. Marks: 100

Important Instructions:

--- Content provided by​ FirstRanker.com ---

1. Attempt all questions in order.
2. Each question carries 10 marks.
3. Read the question carefully and answer to the point neatly and legibly.
4. Do not leave any blank pages between two answers.
5. Indicate the question number correctly for the answer in the margin space.

--- Content provided by FirstRanker.com ---

6. Answer all the parts of a single question together.
7. Start the answer to a question on a fresh page or leave adequate space between two answers.
8. Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. a) Indications of cardiac transplantation. (3+7)
   

   --- Content provided by‍ FirstRanker.com ---

   b) Diagnosis and management of rejection in cardiac transplantation.
2. Classify mediastinal tumours. (5+5)
   Diagnosis and management of anterior mediastinal tumours.
3. Role of cell saver in cardiac surgery. (5+5)
4. Bio-glue. (5+5)
   

   --- Content provided by‌ FirstRanker.com ---

   Cardiopulmonary bypass in minimally invasive cardiac surgery.
   Complications of peripheral cannulation.
5. Intra-Aortic Balloon Pump: (4+3+3)
   a) Indications.
   b) Contraindications.
   

   --- Content provided by FirstRanker.com ---

   c) Mechanism of action.
6. Discuss various surgical techniques in heart failure. (5+5)
7. Role of stem cell therapy in heart failure. (5+5)
8. Indications of TAVL (5+5)
   Complications of esophagectomy.

--- Content provided by⁠ FirstRanker.com ---

9. TNM staging and management of esophageal cancers. (5+5)
   Complication and esophagectomy.
10. a) Classification and etiopathogenesis of aortic dissection. (2+4+4)
    b) Discuss about TEVAR.
    c) EXCEL trial.
    

    --- Content provided by⁠ FirstRanker.com ---

    Current status of MAZE procedure.
    Anti-failure drugs.